Company Filing History:
2 out of 3 
1 out of 17 
1 out of 2 Years Active: 1999-2019
Title: Christopher John Wraight: Innovator in Pharmaceutical Research
Introduction
Christopher John Wraight is a notable inventor based in Blackburn, Australia. He has made significant contributions to the field of pharmaceutical research, holding a total of five patents. His work primarily focuses on developing innovative treatments for various medical conditions.
Latest Patents
Among his latest patents is a pharmaceutical composition comprising betahistine. This composition is designed for the treatment of otological or neurological disorders in human subjects through intranasal application. Another significant patent involves the modulation of insulin-like growth factor I receptor expression in cancer. This patent outlines methods, compounds, and compositions aimed at reducing the expression of IGF-IR mRNA and protein in animals, which can be beneficial in treating or preventing tumors and cancer symptoms.
Career Highlights
Christopher has worked with esteemed organizations such as the Royal Children's Hospital Research Foundation and Antisense Therapeutics Limited. His experience in these institutions has allowed him to contribute to groundbreaking research and development in the pharmaceutical sector.
Collaborations
Some of his notable coworkers include George Arthur Werther and George Tachas. Their collaborative efforts have further advanced the research initiatives they have undertaken together.
Conclusion
Christopher John Wraight's innovative work in pharmaceutical research has led to significant advancements in the treatment of various medical conditions. His contributions continue to impact the field positively.